Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring.
Barrons
—
AtaiBeckley and Compass Pathways are two drugmakers developing psychedelic treatments for depression.
Trump's psychedelics executive order
- Compass Pathways CEO on Trump's Order to Expand Psychedelics Research Bloomberg —
- FDA's Makary on Trump EO to Ease Access to Psychedelics Bloomberg —
- Trump’s order on psychedelics could have far-reaching science consequences Scientific American —
- How Trump's psychedelics executive order could unlock stalled cannabis reform CNBC —
- Trump administration moves forward with certain drug reclassifications CBS News —